AKT1 and gastric cancer: Enhancement of the anticancer effect of anticancer medicines: APS increased the anticancer effects of apatinib on gastric cancer AGS cells by lowering the levels of phosphorylated AKT and MMP-9 in the AKT signaling pathway [118].